🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the effectiveness of niraparib in ...
Status
Active Not Recruiting
Location
Urology Centers Of Alabama
Start Date
2019-01-25
Trial ID
NCT03748641
This phase II trial studies how well docetaxel or abiraterone acetate work ...
Status
Terminated
Location
Huntsman Cancer Institute/University of Utah
Start Date
2019-02-08
Trial ID
NCT03827473
This randomized phase III trial studies enzalutamide to see how well it wor...
Status
Unknown
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-01-22
Trial ID
NCT01949337
Treatments Being Tested
This study will assess the efficacy and safety of capivasertib plus abirate...
Status
Active Not Recruiting
Location
Research Site
Start Date
2020-07-13
Trial ID
NCT04493853
Treatments Being Tested
This is a phase II, open label, single center study to evaluate the efficac...
Status
Completed
Location
University of California, San Francisco
Start Date
2010-09-10
Trial ID
NCT01199146
Treatments Being Tested
This is a randomized, open-label, three-arm, phase 3 study in men with bioc...
Status
Completed
Location
The Mayo Clinic - Phoenix
Start Date
2017-03-06
Trial ID
NCT03009981
Treatments Being Tested
Asymptomatic patients with metastatic castrate resistant prostate cancer (m...
Status
Recruiting
Location
Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center
Start Date
2023-10-04
Trial ID
NCT06059118
Treatments Being Tested
The purpose of this study is to assess the efficacy, tolerability, safety, ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2022-01-25
Trial ID
NCT05114746
Treatments Being Tested
This Phase 2 Open-label Study examines the efficacy, safety, tolerability, ...
Status
Terminated
Location
Yale Cancer Center
Start Date
2018-11-27
Trial ID
NCT03690141
Treatments Being Tested
This multicenter, international, Phase Ib/II trial consists of three stages...
Status
Completed
Location
HonorHealth Research Institute ? Bisgrove
Start Date
2012-01-11
Trial ID
NCT01485861
Treatments Being Tested